We are deep domain experts in Biopharma | Biotech | Healthcare
We are an AI-native consultancy
We make sense of a world of increasing uncertainty
Biopharma, Biotech, Healthcare, Med Tech, AI & Digital Health, Gene & Cell Therapeutics, CDMO, Medical Devices, & more.
The Life Sciences, especially biopharma and biotech, are in a new era, using AI, digital data, and analytics to bring life-saving medicines to patients faster. This pandemic-accelerated transformation is reshaping everything from R&D to M&A. AGMI’s biopharma and biotech experts help companies lead this evolution, accelerating next-generation capabilities for significant growth and sustained value creation.
Our services include:
-
Scientific Due Diligence
-
Equity Story Development
-
Strategic Partnerships & Licensing Portfolio Strategy
-
Competitive Landscape Analyses & Asset Differentiation
-
Capital Raising
-
Market Entry & Exit Strategies

Healthcare enterprises are living in an unprecedented era of disruption and technological shifts. AGMI’s healthcare and AI experts analyze and contextualize the major pain points across care delivery transformation, cost optimization, operational excellence, access & affordability strategy, digital health technology enablement, and more.
Our services include:
- Leading service line transformations in specialties like oncology and neurology
- Redesigning clinical workflows to enhance productivity, reduce burnout, and improve healthcare provider/user satisfaction
- Designing and executing value-based care models to align clinical outcomes with financial sustainability
- Design and implement digitally-enabled manufacturing operations to achieve best-in-class productivity and quality
- Craft compelling corporate strategies and equity narratives to facilitate successful financing rounds and IPO preparations


Pricing, access & reimbursement strategy

Customer-centric engagement

Launch strategy & planning

Equity story development

Scientific & commercial due diligence
